Correction: The impact of white matter lesions on seizure recurrence after first epileptic seizures in the elderly: a prospective study
Jenny Weil, Louise Linka, Mariana Gurschi, Seyyid Abdulkerim Kidik, Alena Fuchs, Rebecca Schoenfeldt, Felix Zahnert, Leona Möller, Katja Menzler, André Kemmling, Susanne Knake, Lena Habermehl

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEpilepsy research and treatment
Correction: Neurological Research and Practice (2025) 7:36
10.1186/s42466-025-00391-2
Due to a typesetting mistake, the values in the rows ‘Tumor/Metastasis’ and ‘Hippocampal sclerosis’ in Table 1 were incorrectly given.
Table 1. Sample characteristics in patients with unprovoked seizure (n = 168)EPI (n = 15)EWML (n = 60)OWML (n = 93)Characteristics n % N
%
n %Sex Female 3
20.0
27
45.0
50
53.8 Male 12
80.0
33
55.0
43
46.2 Seizure recurrence reported* 9
64.3
13
30.2
11
18.0 Diagnosis of epilepsy 15
100.0
57
95.0
63
67.7 Antiseizure medication started 15
100.0
58
96.7
70
75.3 Status epilepticus as first seizure 4
26.7
16
26.7
17
18.3 Death during study-period 3
20.0
20
33.3
21
22.6 Neuroimaging MRI 5
33.3
44
73.3
70
75.3 CT** 10
66.7
16
26.7
23
24.7 Potentially epileptogenic findings*** Postischemic lesion 7
46.7
31
51.7
–
– Posthemorrhagic lesion 5
33.3
14
23.3
–
– Tumor/Metastasis 3
20.0
20
33.3
21
22.6 Hippocampal sclerosis 1
6.7
31
51.7
–
– Cortical dysplasia 0
0.0
1
1.7
–
– Cavernoma 1
6.7
0
0.0
–
– EEG Epileptiform discharge 1
6.7
15
25.0
25
26.9 No epileptiform findings 14
93.3
44
73.3
67
72.0 No EEG 0
0.0
1
1.7
1
1.1 EPI = only presumed epileptogenic lesions on neuroimaging, EWML presumed epileptogenic lesions and white matter lesions on neuroimaging, OWML = only white matter lesions on neuroimaging^^EPI: n = 14, EWML: n = 43, OWML: n = 61, lost to follow-up: n = 50^^CT was only assessed by patients without MRI^^In the EPI group two of 15 patients got two potentially epileptogenic findings and in the EWML group 12 of 60 patients got two potentially epileptogenic findings
Corrected Table 1:
Table 1. Sample characteristics in patients with unprovoked seizure (n = 168)EPI (n = 15)EWML (n = 60)OWML (n = 93)Characteristics n % N
%
n %Sex Female 3
20.0
27
45.0
50
53.8 Male 12
80.0
33
55.0
43
46.2 Seizure recurrence reported* 9
64.3
13
30.2
11
18.0 Diagnosis of epilepsy 15
100.0
57
95.0
63
67.7 Antiseizure medication started 15
100.0
58
96.7
70
75.3 Status epilepticus as first seizure 4
26.7
16
26.7
17
18.3 Death during study-period 3
20.0
20
33.3
21
22.6 Neuroimaging MRI 5
33.3
44
73.3
70
75.3 CT** 10
66.7
16
26.7
23
24.7 Potentially epileptogenic findings*** Postischemic lesion 7
46.7
31
51.7
–
– Posthemorrhagic lesion 5
33.3
14
23.3
–
– Tumor/Metastasis 3
20.0
23
38.3 -- Hippocampal sclerosis 1
6.7
3
5.0
–
– Cortical dysplasia 0
0.0
1
1.7
–
– Cavernoma 1
6.7
0
0.0
–
– EEG Epileptiform discharge 1
6.7
15
25.0
25
26.9 No epileptiform findings 14
93.3
44
73.3
67
72.0 No EEG 0
0.0
1
1.7
1
1.1 EPI = only presumed epileptogenic lesions on neuroimaging, EWML = presumed epileptogenic lesions and white matter lesions on neuroimaging, OWML = only white matter lesions on neuroimaging^^EPI: n = 14, EWML: n = 43, OWML: n = 61, lost to follow-up: n = 50^^CT was only assessed by patients without MRI^^In the EPI group two of 15 patients got two potentially epileptogenic findings and in the EWML group 12 of 60 patients got two potentially epileptogenic findings
The original article has been corrected.
